Cell Transformation, Neoplastic
"Cell Transformation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Descriptor ID |
D002471
|
| MeSH Number(s) |
C04.697.098.500 C23.550.727.098.500
|
| Concept/Terms |
Cell Transformation, Neoplastic- Cell Transformation, Neoplastic
- Tumorigenic Transformation
- Transformation, Tumorigenic
- Transformations, Tumorigenic
- Tumorigenic Transformations
- Transformation, Neoplastic Cell
- Neoplastic Cell Transformation
- Cell Transformations, Neoplastic
- Neoplastic Cell Transformations
- Transformations, Neoplastic Cell
- Neoplastic Transformation, Cell
- Cell Neoplastic Transformation
- Cell Neoplastic Transformations
- Neoplastic Transformations, Cell
- Transformation, Cell Neoplastic
- Transformations, Cell Neoplastic
|
Below are MeSH descriptors whose meaning is more general than "Cell Transformation, Neoplastic".
Below are MeSH descriptors whose meaning is more specific than "Cell Transformation, Neoplastic".
This graph shows the total number of publications written about "Cell Transformation, Neoplastic" by people in this website by year, and whether "Cell Transformation, Neoplastic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 2 | 0 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Transformation, Neoplastic" by people in Profiles.
-
Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis. EBioMedicine. 2019 Dec; 50:55-66.
-
Microenvironment meets lineage complexity in junctional tumorigenesis. Nat Commun. 2019 08 23; 10(1):3829.
-
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression. Nat Immunol. 2019 07; 20(7):835-851.
-
Epithelial oestrogen receptor a is dispensable for the development of oestrogen-induced cervical neoplastic diseases. J Pathol. 2018 06; 245(2):147-152.
-
Novel SUMO-Protease SENP7S Regulates ?-catenin Signaling and Mammary Epithelial Cell Transformation. Sci Rep. 2017 04 21; 7:46477.
-
SENP1 regulates PTEN stability to dictate prostate cancer development. Oncotarget. 2017 Mar 14; 8(11):17651-17664.
-
24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development. Proc Natl Acad Sci U S A. 2016 10 11; 113(41):E6219-E6227.
-
Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/ß-catenin signaling. Oncotarget. 2016 May 24; 7(21):31413-28.
-
IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo. Nature. 2015 Jan 29; 517(7536):626-30.
-
Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice. Carcinogenesis. 2014 Feb; 35(2):489-96.